SFE-AFCE-SFMN 2022 consensus on the management of thyroid nodules: Surgical treatment.
Approach
Consensus
Hematoma
Hypocalcemia
Loboisthmectomy
Neck dissection
Neuromonitoring
Outpatient surgery
Recurrent nerve palsy
Surgery
Thyroid nodule
Total thyroidectomy
Journal
Annales d'endocrinologie
ISSN: 2213-3941
Titre abrégé: Ann Endocrinol (Paris)
Pays: France
ID NLM: 0116744
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
pubmed:
30
10
2022
medline:
17
12
2022
entrez:
29
10
2022
Statut:
ppublish
Résumé
The SFE-AFCE-SFMN 2022 consensus deals with the management of thyroid nodules, a condition that is a frequent reason for consultation in endocrinology. In more than 90% of cases, patients are euthyroid, with benign non-progressive nodules that do not warrant specific treatment. The clinician's objective is to detect malignant thyroid nodules at risk of recurrence and death, toxic nodules responsible for hyperthyroidism or compressive nodules warranting treatment. The diagnosis and treatment of thyroid nodules requires close collaboration between endocrinologists, nuclear medicine physicians and surgeons, but also involves other specialists. Therefore, this consensus statement was established jointly by 3 societies: the French Society of Endocrinology (SFE), French-speaking Association of Endocrine Surgery (AFCE) and French Society of Nuclear Medicine (SFMN); the various working groups included experts from other specialties (pathologists, radiologists, pediatricians, biologists, etc.). This section deals with the surgical management of thyroid nodules.
Identifiants
pubmed: 36309207
pii: S0003-4266(22)00856-3
doi: 10.1016/j.ando.2022.10.012
pii:
doi:
Types de publication
Practice Guideline
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
415-422Informations de copyright
Copyright © 2022. Published by Elsevier Masson SAS.